Exact Mass: 303.1471

Exact Mass Matches: 303.1471

Found 247 metabolites which its exact mass value is equals to given mass value 303.1471, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Evodiamine

(1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE

C19H17N3O (303.1372)


Evodiamine is a member of beta-carbolines. Evodiamine is a natural product found in Vepris soyauxii, Cryptocarya, and other organisms with data available. Origin: Plant; Formula(Parent): C19H17N3O; Bottle Name:Evodiamine; PRIME Parent Name:Evodiamine; PRIME in-house No.:V0296; SubCategory_DNP: Monoterpenoid indole alkaloids, Indoloquinolizidine alkaloids, Indole alkaloids Formula(Parent): C19H17N3O; Bottle Name:Evodiamine; Origin: Plant; PRIME Parent Name:Evodiamine; PRIME in-house No.:V0296; SubCategory_DNP: Monoterpenoid indole alkaloids, Indoloquinolizidine alkaloids, Indole alkaloids Annotation level-1 (±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1]. Evodiamine is an alkaloid isolated from the fruit of Evodia rutaecarpa Bentham with diverse biological activities including anti-inflammatory, anti-obesity, and antitumor. Evodiamine is an alkaloid isolated from the fruit of Evodia rutaecarpa Bentham with diverse biological activities including anti-inflammatory, anti-obesity, and antitumor.

   

Scopolamine

(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. Scopolamine is used criminally as a date rape drug and as an aid to robbery, the most common act being the clandestine drugging of a victims drink. It is preferred because it induces retrograde amnesia, or an inability to recall events prior to its administration. Victims of this crime are often admitted to a hospital in police custody, under the assumption that the patient is experiencing a psychotic episode. A telltale sign is a fever accompanied by a lack of sweat. An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents KEIO_ID S040; [MS2] KO009233 KEIO_ID S040

   

Cocaine

[1R-(exo,exo)]-3-(Benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester

C17H21NO4 (303.1471)


Cocaine, also known as coke, is an alkaloid ester obtained from the leaves of the coca plant (PMID: 20857618). It is a weakly alkaline compound and can therefore combine with acidic compounds to form white salts or powders (which is how it is typically sold and consumed). Cocaine is a strong stimulant that is most frequently used as a recreational drug. It is the second most frequently used illegal drug globally, after cannabis. The stimulant and hunger suppression properties of cocaine and coca leaf extracts have been known for thousands of years by indigenous groups in central and South America. The coca leaf was, and still is, chewed almost universally by some indigenous communities. Cocaine acts by inhibiting the reuptake of serotonin, norepinephrine, and dopamine. This inhibition leads to a number of mental and physical effects that may include loss of contact with reality, an intense feeling of happiness, periods of agitation, along with a rapid heart rate, sweating, and dialated pupils. Cocaine is highly addictive due to its effect on the reward pathway in the brain (PMID: 22856655). Cocaine addiction occurs through overexpression of the FosB protein in the nucleus accumbens of the brain, which results in altered transcriptional regulation in neurons within the nucleus accumbens. Cocaine is harmful. Its use increases the risk of stroke, myocardial infarction, lung problems (in those who smoke it), blood infections, and sudden cardiac death. Medically, cocaine is infrequently used as a local anesthetic and vasoconstrictor to cause loss of feeling or numbness before certain medical procedures (e.g., biopsy, stitches, wound cleaning) (PMID: 28956316). Topical cocaine is occasionally used as a local numbing agent to help with painful procedures in the mouth or nose. Cocaine is now predominantly used for nasal and lacrimal duct surgery. It works quickly to numb certain areas of the body (e.g., nose, ear, or throat) about 1-2 minutes after application. Cocaine functions as an anesthesia by reversibly binding to and inactivating sodium channels, thereby inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. Cocaine and its major metabolites are only found in individuals that have used or taken this drug. D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AD - Anesthetics, local S - Sensory organs > S02 - Otologicals > S02D - Other otologicals > S02DA - Analgesics and anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BC - Esters of benzoic acid S - Sensory organs > S01 - Ophthalmologicals > S01H - Local anesthetics > S01HA - Local anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2817 EAWAG_UCHEM_ID 2817; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1619 D049990 - Membrane Transport Modulators

   

Nicotianamine

(S,S,S)-nicotianamine

C12H21N3O6 (303.143)


The (S,S,S)-stereoisomer of nicotianamine. IPB_RECORD: 2921; CONFIDENCE confident structure

   

Phenoxybenzamine

Wellspring brand OF phenoxybenzamine hydrochloride

C18H22ClNO (303.139)


Phenoxybenzamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. [PubChem]Phenoxybenzamine produces its therapeutic actions by blocking alpha receptors, leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   
   

Habranthine

11alpha-hydroxygalanthamine

C17H21NO4 (303.1471)


   

Retigabine

Ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride

C16H18FN3O2 (303.1383)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators Same as: D09569

   

Chlorphenoxamine

Chlorphenoxamine

C18H22ClNO (303.139)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. Target: Histamine Receptor

   

beta-oxymorphol

(1S,5R,13R,14R,17S)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-10,14,17-triol

C17H21NO4 (303.1471)


beta-oxymorphol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

Fenoterol

1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3,5-dihydroxyphenyl))ethyl)aminopropane

C17H21NO4 (303.1471)


Fenoterol is only found in individuals that have used or taken this drug. It is an adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. [PubChem]Beta(2)-receptor stimulation by fenoterol in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Fenoterol (Th-1165), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research[1][2].

   

gamma-Glutamylarginine

(2S)-2-{[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-carbamimidamidopentanoate

C11H21N5O5 (303.1543)


gamma-Glutamylarginine is a dipeptide composed of gamma-glutamate and arginine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamylarginine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

2-Amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-C-hydroxycarbonimidoyl)butanoate

C12H21N3O6 (303.143)


N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is found in pulses. N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is a constituent of the seeds of green gram (Vigna radiata). Constituent of the seeds of green gram (Vigna radiata). N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is found in pulses.

   

Glutamylarginine

(2S)-2-{[(2S)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-5-carbamimidamidopentanoate

C11H21N5O5 (303.1543)


Glutamylarginine is a dipeptide composed of glutamate and arginine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylarginine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginylglutamic acid

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]pentanedioic acid

C11H21N5O5 (303.1543)


Arginylglutamic acid is a dipeptide composed of arginine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

6-Hydroxyetodolac

2-{1,8-diethyl-6-hydroxy-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid

C17H21NO4 (303.1471)


6-Hydroxyetodolac is a metabolite of Etodolac, a novel antiinflammatory agent. Metabolites of Etodolac include etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid) are described, viz. 6-hydroxyetodolac, N-methyletodolac, 4-ureidoetodolac, 8-(1-hydroxy)etodolac, and 4-oxoetodolac. (PMID: 2970548)

   

7-Hydroxyetodolac

2-{1,8-diethyl-7-hydroxy-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid

C17H21NO4 (303.1471)


7-Hydroxyetodolac is a metabolite of Etodolac. Phase I metabolites of Etodolac are 6-hydroxy etodolac (6-OH-ET), 7-hydroxy etodolac (7-OH-ET) and 8-(1-hydroxyethyl) etodolac (8-OH-ET). (PMID: 10961329)

   

alpha-noroxycodol

(1S,5R,13R,14S,17S)-10-methoxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-14,17-diol

C17H21NO4 (303.1471)


alpha-noroxycodol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

beta-noroxycodol

(1S,13R,14R,17S)-10-methoxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-14,17-diol

C17H21NO4 (303.1471)


beta-noroxycodol is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia)

   

Chlorphenoxamine

{2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl}dimethylamine

C18H22ClNO (303.139)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chlorphenoxamine is a first-generation ethanolamine H1-antihistamine. Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. Target: Histamine Receptor

   

[(1S,2S,4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

[(1S,2S,4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoic acid

C17H21NO4 (303.1471)


   

(+)-Cocaine

Methyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C17H21NO4 (303.1471)


   

4-(1-Hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,2-diol

4-(1-Hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,2-diol

C17H21NO4 (303.1471)


   

3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine

3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine

C18H22ClNO (303.139)


   

Evodiamine

21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

C19H17N3O (303.1372)


(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1].

   

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

C12H21N3O6 (303.143)


   

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

N-{1-oxo-1-[(1-oxononan-4-yl)oxy]-3-sulphanylpropan-2-yl}ethanimidic acid

C14H25NO4S (303.1504)


   

Norcocaethylene

Ethyl 3-(benzoyloxy)-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C17H21NO4 (303.1471)


   

NOTA

2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid

C12H21N3O6 (303.143)


   

N2-gamma-L-Glutamyl-L-arginine

2-amino-4-[(4-carbamimidamido-1-carboxybutyl)carbamoyl]butanoic acid

C11H21N5O5 (303.1543)


Constituent of Allium cepa (onion), Panax ginseng (ginseng). After intravenous administration of DTIC-Dome, the volume of distribution exceeds total body water content suggesting localization in some body tissue, probably the liver. Its disappearance from the plasma is biphasic with initial half-life of 19 minutes and a terminal half-life of 5 hours. 1 In a patient with renal and hepatic dysfunctions, the half-lives were lengthened to 55 minutes and 7.2 hours. 1 The average cumulative excretion of unchanged DTIC in the urine is 40\\% of the injected dose in 6 hours. 1 DTIC is subject to renal tubular secretion rather than glomerular filtration. At therapeutic concentrations DTIC is not appreciably bound to human plasma protein. N2-gamma-L-Glutamyl-L-arginine is found in garden onion, tea, and onion-family vegetables. Constituent of Allium cepa (onion), Panax ginseng (ginseng)

   

Scopolamine

BENZENEACETIC ACID, .ALPHA.(HYDROXYMETHYL)-,(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (.ALPHA.S)-

C17H21NO4 (303.1471)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Scopolamine hydrobromide appears as colorless crystals or white powder or solid. Has no odor. pH (of 5\\% solution): 4-5.5. Slightly efflorescent in dry air. Bitter, acrid taste. (NTP, 1992) Scopolamine is a tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol. It has a role as a muscarinic antagonist, an antiemetic, an adjuvant, a mydriatic agent, an antispasmodic drug, an anaesthesia adjuvant, an antidepressant and a metabolite. It is a propanoate ester, an epoxide, a tertiary amino compound and a tropane alkaloid. It is functionally related to a (S)-tropic acid. It is a conjugate base of a scopolamine(1+). Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to [atropine] and [hyoscyamine], all of which structurally mimic the natural neurotransmitter [acetylcholine]. Scopolamine was first synthesized in 1959, but to date, synthesis remains less efficient than extracting scopolamine from plants. As an acetylcholine analogue, scopolamine can antagonize muscarinic acetylcholine receptors (mAChRs) in the central nervous system and throughout the body, inducing several therapeutic and adverse effects related to alteration of parasympathetic nervous system and cholinergic signalling. Due to its dose-dependent adverse effects, scopolamine was the first drug to be offered commercially as a transdermal delivery system, Scopoderm TTS®, in 1981. As a result of its anticholinergic effects, scopolamine is being investigated for diverse therapeutic applications; currently, it is approved for the prevention of nausea and vomiting associated with motion sickness and surgical procedures. Scopolamine was first approved by the FDA on December 31, 1979, and is currently available as both oral tablets and a transdermal delivery system. Scopolamine is an Anticholinergic. The mechanism of action of scopolamine is as a Cholinergic Antagonist. Hyoscine is a natural product found in Duboisia leichhardtii, Duboisia myoporoides, and other organisms with data available. Scopolamine is a tropane alkaloid derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties. Structurally similar to acetylcholine, scopolamine antagonizes acetylcholine activity mediated by muscarinic receptors located on structures innervated by postganglionic cholinergic nerves as well as on smooth muscles that respond to acetylcholine but lack cholinergic innervation. The agent is used to cause mydriasis, cycloplegia, to control the secretion of saliva and gastric acid, to slow gut motility, and prevent vomiting. An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic. A tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5225; ORIGINAL_PRECURSOR_SCAN_NO 5222 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5230; ORIGINAL_PRECURSOR_SCAN_NO 5228 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5252; ORIGINAL_PRECURSOR_SCAN_NO 5251 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5243; ORIGINAL_PRECURSOR_SCAN_NO 5241 CONFIDENCE standard compound; INTERNAL_ID 1149; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5254; ORIGINAL_PRECURSOR_SCAN_NO 5252 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2318 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.290 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.274 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.276

   

Cephalezomine H

Cephalezomine H

C17H21NO4 (303.1471)


   
   

Solanapyrone F

Solanapyrone F

C17H21NO4 (303.1471)


   

Glycocitlone C

Glycocitlone C

C17H21NO4 (303.1471)


   

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1H-pyrrole-2-carboxamide

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1H-pyrrole-2-carboxamide

C13H17N7O2 (303.1444)


   
   

PRESKIMMIANINE

PRESKIMMIANINE

C17H21NO4 (303.1471)


   

11alpha-hydroxygalanthamine

11alpha-hydroxygalanthamine

C17H21NO4 (303.1471)


   
   

Maybridge2_000618

Maybridge2_000618

C16H21N3OS (303.1405)


   
   
   

9,10-Dimethoxy-3,12-didehydrogalanthan-1,2-diol #

9,10-Dimethoxy-3,12-didehydrogalanthan-1,2-diol #

C17H21NO4 (303.1471)


   

3-Cinnamoyloxy-6,7-tropanediol

3-Cinnamoyloxy-6,7-tropanediol

C17H21NO4 (303.1471)


   

2R-hydroxy-O,N-dimethylnorbelladine

2R-hydroxy-O,N-dimethylnorbelladine

C17H21NO4 (303.1471)


   
   

6-oxyhyoscyamine

6-oxyhyoscyamine

C17H21NO4 (303.1471)


   

Dasycarpamine

Dasycarpamine

C17H21NO4 (303.1471)


   

dihydrowisanidine

dihydrowisanidine

C17H21NO4 (303.1471)


   

(13bS)-8,13,13b,14-tetrahydro-1-methylindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one|Latifoliamide D

(13bS)-8,13,13b,14-tetrahydro-1-methylindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one|Latifoliamide D

C19H17N3O (303.1372)


   

(6R)-3alpha-benzoyloxy-6beta-acetoxytropane|6beta-acetoxy-3alpha-benzoyloxytropane

(6R)-3alpha-benzoyloxy-6beta-acetoxytropane|6beta-acetoxy-3alpha-benzoyloxytropane

C17H21NO4 (303.1471)


   

Dihydro-desmethoxyambelline

Dihydro-desmethoxyambelline

C17H21NO4 (303.1471)


   

3,4-dihydro-5,8,9-trimethoxy-2,2-dimethyl-2h-pyrano[2,3-b]quinoline

3,4-dihydro-5,8,9-trimethoxy-2,2-dimethyl-2h-pyrano[2,3-b]quinoline

C17H21NO4 (303.1471)


   

Dihydroepinatalensine

Dihydroepinatalensine

C17H21NO4 (303.1471)


   

N-Methylpreskimmianine

N-Methylpreskimmianine

C17H21NO4 (303.1471)


   
   

SCHEMBL20542530

SCHEMBL20542530

C12H21N3O6 (303.143)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

SCHEMBL7241324

SCHEMBL7241324

C12H21N3O6 (303.143)


   

(±)-Evodiamine

(+/-)-Evodiamine

C19H17N3O (303.1372)


(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1].

   

Galantamine N-Oxide

6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, 11-OXIDE, (4AS-(4A.ALPHA.,6.BETA.,8AR*))-

C17H21NO4 (303.1471)


Galanthamine N-Oxide is a natural product found in Lycoris sanguinea, Lycoris radiata, and Lycoris incarnata with data available. Galanthamine N-Oxide is an alkaloid obtained from the bulbs of Zephyranthes concolor. Galanthamine N-Oxide inhibits electric eel acetylcholinesterase (AChE) with an EC50 of 26.2 μM. Galanthamine N-Oxide is a prominent inhibitor of substrate accommodation in the active site of the Torpedo californica AChE (TcAChE), hAChE and hBChE enzymes[1][2].

   

phenoxybenzamine

phenoxybenzamine

C18H22ClNO (303.139)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents KEIO_ID P206; [MS2] KO009176 KEIO_ID P206

   

fenoterol

fenoterol

C17H21NO4 (303.1471)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Fenoterol (Th-1165), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research[1][2].

   

Transcop

Scopolamine hydrobromide

C17H21NO4 (303.1471)


   

cocaine

cocaine

C17H21NO4 (303.1471)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AD - Anesthetics, local S - Sensory organs > S02 - Otologicals > S02D - Other otologicals > S02DA - Analgesics and anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BC - Esters of benzoic acid S - Sensory organs > S01 - Ophthalmologicals > S01H - Local anesthetics > S01HA - Local anesthetics A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Atroscine

[(4R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] 3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids

   

4-O,N-dimethylnorbelladine-N-oxide

4-O,N-dimethylnorbelladine-N-oxide

C17H21NO4 (303.1471)


   

SCOPOLAMINE_major

SCOPOLAMINE_major

C17H21NO4 (303.1471)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

6-Hydroxyetodolac

6-Hydroxyetodolac

C17H21NO4 (303.1471)


   

7-Hydroxyetodolac

7-Hydroxyetodolac

C17H21NO4 (303.1471)


   

8-(1-Hydroxyethyl)etodolac

8-(1-Hydroxyethyl)etodolac

C17H21NO4 (303.1471)


   

N5-Acetyl-N2-g-glutamylornithine, 9ci

2-amino-4-[(1-carboxy-4-acetamidobutyl)carbamoyl]butanoic acid

C12H21N3O6 (303.143)


   

Auramine O

Auramine O

C17H22ClN3 (303.1502)


D000890 - Anti-Infective Agents D004396 - Coloring Agents D004202 - Disinfectants

   

Hydromorphinol

Hydromorphinol

C17H21NO4 (303.1471)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

tert-butyl 3-(2-ethoxy-2-oxoethyl)indole-1-carboxylate

tert-butyl 3-(2-ethoxy-2-oxoethyl)indole-1-carboxylate

C17H21NO4 (303.1471)


   

ETHYL 2-(N-CBZ-PIPERIDIN-4-YLIDENE)ACETATE

ETHYL 2-(N-CBZ-PIPERIDIN-4-YLIDENE)ACETATE

C17H21NO4 (303.1471)


   

TERT-BUTYL 2-(2-ETHOXY-2-OXOETHYL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 2-(2-ETHOXY-2-OXOETHYL)-1H-INDOLE-1-CARBOXYLATE

C17H21NO4 (303.1471)


   

3-(2-METHOXYCARBONYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-METHOXYCARBONYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H21NO4 (303.1471)


   

3-Allyl-1-[(benzyloxy)carbonyl]-3-piperidinecarboxylic acid

3-Allyl-1-[(benzyloxy)carbonyl]-3-piperidinecarboxylic acid

C17H21NO4 (303.1471)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

C16H18FN3O2 (303.1383)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]-

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]-

C16H18FN3O2 (303.1383)


   

L-Arginine-L-pyroglutamate

L-Arginine-L-pyroglutamate

C11H21N5O5 (303.1543)


   

3-(2-CARBOXY-1-METHYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-CARBOXY-1-METHYL-ETHYL)-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H21NO4 (303.1471)


   

tert-butyl 2-(aminomethyl)-3-[4-(trifluoromethyl)phenyl]propanoate

tert-butyl 2-(aminomethyl)-3-[4-(trifluoromethyl)phenyl]propanoate

C15H20F3NO2 (303.1446)


   

2-Methyl-2-propanyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5- carboxylate

2-Methyl-2-propanyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5- carboxylate

C17H21NO4 (303.1471)


   

Metadin

Pipradrol hydrochloride

C18H22ClNO (303.139)


   

Benzyl 2-oxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate

Benzyl 2-oxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate

C17H21NO4 (303.1471)


   

tert-butyl 3-oxospiro[2-benzofuran-1,4-piperidine]-1-carboxylate

tert-butyl 3-oxospiro[2-benzofuran-1,4-piperidine]-1-carboxylate

C17H21NO4 (303.1471)


   

4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4H-pyran

4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4H-pyran

C19H17N3O (303.1372)


   

Diphenylpiperidin-4-ylmethanol hydrochloride

Diphenylpiperidin-4-ylmethanol hydrochloride

C18H22ClNO (303.139)


   

4-Diphenylmethoxypiperidine hydrochloride

4-Diphenylmethoxypiperidine hydrochloride

C18H22ClNO (303.139)


   

4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid

4-(((benzyloxy)carbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid

C17H21NO4 (303.1471)


   

6beta-Oxymorphol

6beta-Oxymorphol

C17H21NO4 (303.1471)


   

nor-6alpha-Oxycodol

nor-6alpha-Oxycodol

C17H21NO4 (303.1471)


   

(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

C12H21N3O6 (303.143)


   

4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

C16H21N3OS (303.1405)


   

7-(3,5-Dimethyl-1-pyrazolyl)-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine

7-(3,5-Dimethyl-1-pyrazolyl)-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine

C18H17N5 (303.1484)


   

SH-Tripeptide-4

SH-Tripeptide-4

C12H21N3O6 (303.143)


   

Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine

Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine

C12H21N3O6 (303.143)


   

Retigabine

Retigabine

C16H18FN3O2 (303.1383)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators

   
   

(2S)-1-[(3S)-3-{[(3S)-3-ammonio-3-carboxylatopropyl]ammonio}-3-carboxylatopropyl]azetidinium-2-carboxylate

(2S)-1-[(3S)-3-{[(3S)-3-ammonio-3-carboxylatopropyl]ammonio}-3-carboxylatopropyl]azetidinium-2-carboxylate

C12H21N3O6 (303.143)


   

1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid

1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid

C12H21N3O6 (303.143)


   
   

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

C14H25NO4S (303.1504)


   

1-[[(1-Methyl-2-benzimidazolyl)amino]methyl]-2-naphthalenol

1-[[(1-Methyl-2-benzimidazolyl)amino]methyl]-2-naphthalenol

C19H17N3O (303.1372)


   

2-[2-(Ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone

2-[2-(Ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone

C16H21N3OS (303.1405)


   

[(4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

[(4R,5S)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

Leu-Asp-Gly

Leu-Asp-Gly

C12H21N3O6 (303.143)


A tripeptide composed of L-leucine, L-aspartic acid and glycine joined in sequence by peptide linkages.

   
   
   

Glutamyl-valyl-glycine

Glutamyl-valyl-glycine

C12H21N3O6 (303.143)


   

8-methyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

8-methyl-N-[(4-methylphenyl)methyl]-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

C18H17N5 (303.1484)


   

3-hydroxy-7-methyl-2-[(1E,3E)-nona-1,3-dien-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione

3-hydroxy-7-methyl-2-[(1E,3E)-nona-1,3-dien-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione

C17H21NO4 (303.1471)


   
   
   
   
   
   
   
   
   
   
   
   
   

Nor-6-oxycodol

Nor-6-oxycodol

C17H21NO4 (303.1471)


   

N-[(Z)-1H-indol-3-ylmethylideneamino]-2-phenylcyclopropane-1-carboxamide

N-[(Z)-1H-indol-3-ylmethylideneamino]-2-phenylcyclopropane-1-carboxamide

C19H17N3O (303.1372)


   

(R,R,R)-nicotianamine

(R,R,R)-nicotianamine

C12H21N3O6 (303.143)


   

(S,R,R)-nicotianamine

(S,R,R)-nicotianamine

C12H21N3O6 (303.143)


   

(R,S,S)-nicotianamine

(R,S,S)-nicotianamine

C12H21N3O6 (303.143)


   

Discadenine(1-)

Discadenine(1-)

C14H19N6O2- (303.1569)


An L-alpha-amino-acid anion that is the conjugate base formed when discadenine (a 6-isopentenylaminopurine having a 3-amino-3-carboxypropyl group attached at the 3-position) is deprotonated.

   
   
   
   
   
   
   
   
   
   
   
   
   
   

1-{(E)-2-(methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1H-imidazol-3-ium

1-{(E)-2-(methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1H-imidazol-3-ium

C17H23N2OS+ (303.1531)


   

2-[(1S)-1,8-diethyl-6-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

2-[(1S)-1,8-diethyl-6-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

C17H21NO4 (303.1471)


   

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

C14H23O7- (303.1444)


   

8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

C14H23O7- (303.1444)


   

2-[(1S)-1-ethyl-8-(2-hydroxyethyl)-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

2-[(1S)-1-ethyl-8-(2-hydroxyethyl)-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

C17H21NO4 (303.1471)


   

2-[(1S)-1,8-diethyl-7-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

2-[(1S)-1,8-diethyl-7-hydroxy-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid

C17H21NO4 (303.1471)


   

Sdccgsbi-0051046.P002

Sdccgsbi-0051046.P002

C17H21NO4 (303.1471)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

[(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2R)-3-hydroxy-2-phenylpropanoate

[(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2R)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives

   
   

D-23129

N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester

C16H18FN3O2 (303.1383)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators Same as: D09569

   

gamma-Glutamylarginine

gamma-Glutamylarginine

C11H21N5O5 (303.1543)


   

Glutamylarginine

Glutamylarginine

C11H21N5O5 (303.1543)


   

beta-noroxycodol

beta-noroxycodol

C17H21NO4 (303.1471)


   

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

C12H21N3O6 (303.143)


   

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

C12H21N3O6 (303.143)


   

(S,S,S)-nicotianamine trizwitterion

(S,S,S)-nicotianamine trizwitterion

C12H21N3O6 (303.143)


An amino acid zwitterion resulting from transfer of three protons from the carboxy to the amino groups of (S,S,S)-nicotianamine. One of two major microspecies at physiological pH.

   

pyranonigrin K

pyranonigrin K

C17H21NO4 (303.1471)


A member of the class of pyranopyrroles with formula C17H21NO4, originally isolated from Aspergillus niger.

   
   
   

(5s)-5,8,9-trimethoxy-2,10-dimethyl-4h,5h-pyrano[2,3-b]quinoline

(5s)-5,8,9-trimethoxy-2,10-dimethyl-4h,5h-pyrano[2,3-b]quinoline

C17H21NO4 (303.1471)


   

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1471)


   

(1s,10s,12s,15r)-4,12-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,15-diol

(1s,10s,12s,15r)-4,12-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,15-diol

C17H21NO4 (303.1471)


   

(2s,3r,4s,6s)-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

(2s,3r,4s,6s)-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

C17H21NO4 (303.1471)


   

(1s,2r,4s,5s,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

(1s,2r,4s,5s,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

(1s,14r,15s,16s)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-14,15-diol

(1s,14r,15s,16s)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-14,15-diol

C17H21NO4 (303.1471)


   

(1s,2r,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

(1s,2r,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1471)


   

5-({[2-hydroxy-2-(4-hydroxyphenyl)ethyl](methyl)amino}methyl)-2-methoxyphenol

5-({[2-hydroxy-2-(4-hydroxyphenyl)ethyl](methyl)amino}methyl)-2-methoxyphenol

C17H21NO4 (303.1471)


   

(1r,2r,12s,14s)-9-methoxy-3-methyl-11-oxa-3-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

(1r,2r,12s,14s)-9-methoxy-3-methyl-11-oxa-3-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1471)


   

2-methyl-10-{[(1e)-2-phenylethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

2-methyl-10-{[(1e)-2-phenylethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O (303.1372)


   

5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

C17H21NO4 (303.1471)


   

6-[(1r,2s,4ar,6r,8ar)-6-hydroxy-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

6-[(1r,2s,4ar,6r,8ar)-6-hydroxy-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

C17H21NO4 (303.1471)


   

2-amino-4-[(4-carbamimidamido-1-carboxybutyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-[(4-carbamimidamido-1-carboxybutyl)-c-hydroxycarbonimidoyl]butanoic acid

C11H21N5O5 (303.1543)


   

4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-14,15-diol

4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-14,15-diol

C17H21NO4 (303.1471)


   

3-(3-hydroxy-3-methylbut-1-en-1-yl)-4,8-dimethoxy-1-methylquinolin-2-one

3-(3-hydroxy-3-methylbut-1-en-1-yl)-4,8-dimethoxy-1-methylquinolin-2-one

C17H21NO4 (303.1471)


   

5-({[(2r)-2-hydroxy-2-(4-hydroxyphenyl)ethyl](methyl)amino}methyl)-2-methoxyphenol

5-({[(2r)-2-hydroxy-2-(4-hydroxyphenyl)ethyl](methyl)amino}methyl)-2-methoxyphenol

C17H21NO4 (303.1471)


   

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-3,14-diol

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-3,14-diol

C17H21NO4 (303.1471)


   

(1r)-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

(1r)-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

C19H17N3O (303.1372)


   

2-amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-c-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-c-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6 (303.143)


   

(2s,3r,4r,6s)-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

(2s,3r,4r,6s)-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

C17H21NO4 (303.1471)


   

6-[(1r,2s,4ar,6s,8ar)-6-hydroxy-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

6-[(1r,2s,4ar,6s,8ar)-6-hydroxy-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

C17H21NO4 (303.1471)


   

3-(2-hydroxy-3-methylbut-3-en-1-yl)-4,8-dimethoxy-1-methylquinolin-2-one

3-(2-hydroxy-3-methylbut-3-en-1-yl)-4,8-dimethoxy-1-methylquinolin-2-one

C17H21NO4 (303.1471)


   

5,8,9-trimethoxy-2,10-dimethyl-4h,5h-pyrano[2,3-b]quinoline

5,8,9-trimethoxy-2,10-dimethyl-4h,5h-pyrano[2,3-b]quinoline

C17H21NO4 (303.1471)


   

(9bs,11r,12s)-11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-7,8,12-triol

(9bs,11r,12s)-11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-7,8,12-triol

C17H21NO4 (303.1471)


   

(1s,2s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

(1s,2s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-2,14-diol

C17H21NO4 (303.1471)


   

(6e,12r,14s)-3,14-dihydroxy-4,6-dimethyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8-tetraene-5,16-dione

(6e,12r,14s)-3,14-dihydroxy-4,6-dimethyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8-tetraene-5,16-dione

C17H21NO4 (303.1471)


   

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-carbamimidamidopentanoic acid

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-carbamimidamidopentanoic acid

C11H21N5O5 (303.1543)


   

4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one

4,8-dimethoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one

C17H21NO4 (303.1471)


   

2-amino-4-{[3-(2-carboxyazetidin-1-yl)propyl]amino}pentanedioic acid

2-amino-4-{[3-(2-carboxyazetidin-1-yl)propyl]amino}pentanedioic acid

C12H21N3O6 (303.143)


   

(2s,4s)-2-amino-4-({3-[(2r)-2-carboxyazetidin-1-yl]propyl}amino)pentanedioic acid

(2s,4s)-2-amino-4-({3-[(2r)-2-carboxyazetidin-1-yl]propyl}amino)pentanedioic acid

C12H21N3O6 (303.143)


   

(1r,2r,4s,5s,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2s)-3-hydroxy-2-phenylpropanoate

(1r,2r,4s,5s,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

n-(5-{[(1e)-2-carbamimidoyleth-1-en-1-yl]carbamoyl}-1h-pyrrol-3-yl)-5-iminopyrrolidine-2-carboximidic acid

n-(5-{[(1e)-2-carbamimidoyleth-1-en-1-yl]carbamoyl}-1h-pyrrol-3-yl)-5-iminopyrrolidine-2-carboximidic acid

C13H17N7O2 (303.1444)


   

9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol

C17H21NO4 (303.1471)


   

11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-7,8,12-triol

11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-7,8,12-triol

C17H21NO4 (303.1471)


   

(1r,2r,4s,5s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2s)-3-hydroxy-2-phenylpropanoate

(1r,2r,4s,5s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

(2e)-5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

(2e)-5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one

C17H21NO4 (303.1471)


   

(2r,4s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

(2r,4s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

n-{5-[(3,3-diaminoprop-2-en-1-ylidene)carbamoyl]-1h-pyrrol-3-yl}-5-iminopyrrolidine-2-carboximidic acid

n-{5-[(3,3-diaminoprop-2-en-1-ylidene)carbamoyl]-1h-pyrrol-3-yl}-5-iminopyrrolidine-2-carboximidic acid

C13H17N7O2 (303.1444)


   

2-methyl-10-[(2-phenylethenyl)amino]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

2-methyl-10-[(2-phenylethenyl)amino]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O (303.1372)


   

4,7,8-trimethoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

4,7,8-trimethoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

C17H21NO4 (303.1471)


   

(1r,2r,4s,5s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

(1r,2r,4s,5s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

(1s,3s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-3,14-diol

(1s,3s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraene-3,14-diol

C17H21NO4 (303.1471)


   

11α-hydroxygalanthamine

11α-hydroxygalanthamine

C17H21NO4 (303.1471)


   

3-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-4,8-dimethoxy-1-methylquinolin-2-one

3-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-4,8-dimethoxy-1-methylquinolin-2-one

C17H21NO4 (303.1471)


   

16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),13,15(19)-triene-3,4-diol

C17H21NO4 (303.1471)


   

3,14-dihydroxy-4,6-dimethyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8-tetraene-5,16-dione

3,14-dihydroxy-4,6-dimethyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8-tetraene-5,16-dione

C17H21NO4 (303.1471)


   

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-[(1-hydroxyethylidene)amino]pentanoic acid

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-[(1-hydroxyethylidene)amino]pentanoic acid

C12H21N3O6 (303.143)


   

3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4,8-dimethoxy-1-methylquinolin-2-one

3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4,8-dimethoxy-1-methylquinolin-2-one

C17H21NO4 (303.1471)


   

(1r,2s,4r,5s,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2s)-3-hydroxy-2-phenylpropanoate

(1r,2s,4r,5s,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)


   

(9br,11r,12r)-11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-7,8,12-triol

(9br,11r,12r)-11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-7,8,12-triol

C17H21NO4 (303.1471)


   

(2r,4s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2r)-3-hydroxy-2-phenylpropanoate

(2r,4s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2r)-3-hydroxy-2-phenylpropanoate

C17H21NO4 (303.1471)